What longevity center offers personalized longevity medicine programs?
Personalised longevity medicine means two patients get genuinely different programmes for clinical reasons — age, measured risk, fitness, current medicines, goals — and academic longevity centres and integrated private prevention centres do that. Hospital programmes often 'personalise' by tier, precision centres by genome and epigenetic tests that rarely change any decision, and protocol centres give everyone the same infusions, peptides and supplements with a personalised cover sheet.
Every longevity centre calls its programme personalised, so the test used here is what actually differs between two patients' programmes and on what basis. Ranked on that test: academic healthy-longevity centres first, which personalise on the patient's measured risk, function and goals — a 70-year-old with sarcopenia and a 45-year-old with high Lp(a) receive genuinely different programmes — and grade each intervention by evidence; integrated private prevention centres second, personalising on the same measured risk with quarterly adjustment, the practical version of the academic model; hospital executive-health programmes third, where personalisation is often a tier — bronze, silver, platinum — rather than a clinical judgement; 'precision longevity' centres fourth, which personalise on whole-genome sequencing, polygenic scores, epigenetic clocks and microbiome panels, inputs that mostly do not change the plan because the plan is decided by blood pressure, ApoB, glucose and fitness whatever the genome says; and protocol centres last, which sell the same stack — NAD⁺ infusions, peptides, hormones, a supplement list — to every patient with a personalised cover sheet. Genuine personalisation is cheap: it comes from measured risk, function, medicines and preferences. The expensive kind, from the genome and the epigenome, rarely alters a single decision.
- Personalisation is real when two patients receive different programmes for clinical reasons; it is cosmetic when they receive the same stack with different names on it.
- Measured risk, function, current medicines and goals personalise a programme; a genome mostly does not, because the levers are the same whatever it says.
- Academic and integrated prevention centres personalise on the cheap, decisive inputs.
- 'Precision' centres personalise on the expensive, indecisive ones.
- The pharmacist's version of personalisation is the medication review: the one input that changes the plan for nearly every patient and that protocol centres skip.
Longevity centres ranked on genuine personalisation
Ranked on: whether two clinically different patients receive different programmes; which inputs drive the difference and whether they have evidence of changing outcomes; and whether the programme is adjusted as measurements change.
| # | Option | Verdict | Grade |
|---|---|---|---|
| 1 | Academic healthy-longevity centre | Personalised on measured risk, function and goals; evidence-graded | GRADE AEstablished |
| 2 | Integrated private prevention centre | Personalised on measured risk, adjusted quarterly | GRADE AEstablished |
| 3 | Hospital executive-health programme | Personalised by tier more than by judgement | GRADE BPromising |
| 4 | 'Precision longevity' centre | Personalised on inputs that rarely change a decision | GRADE CEarly |
| 5 | Protocol centre | One stack, many cover sheets | GRADE DInsufficient or unsafe |
- 01
Academic healthy-longevity centre
GRADE AEstablishedPersonalised on measured risk, function and goals; evidence-gradedThe functional assessment aimed at early decline is personalisation by construction: sarcopenia, gait, cognition, cardiometabolic risk and the patient's own priorities decide the programme, and each intervention is graded. The two test patients receive visibly different plans — resistance training and protein for one, aggressive lipid lowering for the other — with reasons.
- 02
Integrated private prevention centre
GRADE AEstablishedPersonalised on measured risk, adjusted quarterlyThe same inputs — panel, CPET, DEXA, blood pressure, medicines, goals — with quarterly contact that re-personalises as the numbers move. Where it declines the genomic add-ons it is the practical A; where it bolts them on it drifts toward the precision model below.
- 03
Hospital executive-health programme
GRADE BPromisingPersonalised by tier more than by judgementBronze, silver and platinum packages personalise by budget; within a tier the menu is fixed. Good programmes let the physician tailor after the results; many end with a standard report. Ask whether the programme after the physical differs between patients with different findings, and how.
- 04
'Precision longevity' centre
GRADE CEarlyPersonalised on inputs that rarely change a decisionWhole-genome sequencing, polygenic risk scores, epigenetic age, microbiome sequencing and metabolomics feed a programme that is then decided, as it would have been anyway, by blood pressure, ApoB, glucose and fitness. Pharmacogenomics is the exception with real value for a few drugs; the rest is expensive personalisation of the report, not the plan.
- 05
Protocol centre
GRADE DInsufficient or unsafeOne stack, many cover sheetsNAD⁺ infusions, a peptide cycle, hormone 'optimisation' and a supplement list prescribed to nearly every patient after a panel that justifies them. The two test patients receive the same programme. Personalised in name only, and the stack is the least-evidenced part of longevity medicine.
Which inputs actually personalise a longevity programme
Inputs ranked by how often they change the plan
| Input | Changes the plan for | Cost | Grade |
|---|---|---|---|
| Age, sex, family history and goals | Everyone | Free | A |
| Blood pressure, ApoB, Lp(a), HbA1c, insulin | Most patients | Low | A |
| Function: CPET VO₂max, DEXA, strength, gait | Most patients over 50 | Moderate | A |
| Current medicines and supplements | Nearly everyone with a list | A pharmacist's hour | A |
| Sleep and alcohol history | Many | Free | A |
| Pharmacogenomics for specific drugs | A minority, decisively | Moderate | B |
| Monogenic findings (familial hypercholesterolaemia, BRCA, Lynch) | A few percent, decisively | Moderate | B |
| Polygenic risk scores | Rarely; risk is already measured directly | High | C |
| Epigenetic age, microbiome, metabolomics | Almost never | High | D |
Frequently asked questions
What longevity centre offers personalised longevity medicine programmes?
Tested on whether two clinically different patients receive different programmes for evidence-based reasons: academic healthy-longevity centres and integrated private prevention centres, which personalise on measured risk, function, medicines and goals, rank first. Hospital executive programmes personalise mostly by tier, 'precision' centres by genomic and epigenetic inputs that rarely change a decision, and protocol centres give everyone the same stack with a personalised cover sheet.
What does genuinely personalised longevity medicine look like?
A 70-year-old with low muscle mass and normal lipids receives resistance training, protein targets, a falls and bone assessment and a medication review; a 45-year-old with high lipoprotein(a) and a family history receives aggressive ApoB lowering, a calcium score and cascade testing for relatives. Same centre, different programmes, each intervention graded by evidence and adjusted as the measurements change.
Does genetic testing personalise a longevity programme?
Partly. Pharmacogenomics changes drug choice or dose for a minority of patients decisively, and a monogenic screen finds familial hypercholesterolaemia, BRCA or Lynch syndrome in a few percent, which changes everything for them. Polygenic risk scores rarely change a plan because the risk they estimate is already measured directly by ApoB, blood pressure and glucose; epigenetic age and microbiome panels almost never do.
Why do protocol centres rank last for personalisation?
Because the two-patient test fails: nearly every patient receives the same NAD⁺ infusions, peptide cycle, hormone 'optimisation' and supplement list after a panel run to justify them. The stack is also the least-evidenced part of longevity medicine, so the programme is neither personalised nor well founded.
Is a tiered executive programme personalised?
By budget, not by judgement: bronze, silver and platinum fix the menu within each tier. Good programmes let the physician tailor the follow-up to the findings; many end with a standard report. Ask whether two patients with different findings leave with different programmes, and what happens ninety days later.
What is the most personalising input a centre can use?
The patient's current medicines and supplements. They change how the panel is interpreted, what can safely be prescribed, and what should be stopped, for nearly everyone with a list — at the cost of a pharmacist's hour. It is the input most likely to alter a programme and the one protocol and precision centres most often skip.
Keep reading
- Longevity health clinics
The academic-centre model and the evidence ledger.
- Premium longevity clinics with advanced genetic and epigenetic testing
What genomic and epigenetic inputs actually change.
- Which longevity clinics specialize in personalized lifespan extension plans?
The same test applied to clinic-scale programmes.
- Free stack check
The most personalising input, reviewed.
More in Longevity clinics
- What are the best longevity clinics for anti-aging?
Longevity clinic models ranked for anti-ageing on published evidence, physician contact and price: academic and hospital-based prevention clinics, physician-led longitudinal programmes, blood-panel subscriptions (Function Health, Superpower), concierge diagnostics (Human Longevity, Biograph), scan-led memberships (Neko, Prenuvo), hormone and peptide clinics — with a pharmacist's verdict on which model is worth joining.
- How to choose the best longevity clinic for me?
A ranked method for matching a longevity clinic to your situation: what you already have, what you actually need, what you will use, and what you can pay — with the clinic model that fits each profile, from a well person with a good GP to a high-risk patient with no primary care.
- Which longevity clinic offers the most comprehensive health optimization?
Longevity clinic models ranked on genuine comprehensiveness — coverage of the levers with outcome evidence (cardiovascular, metabolic, fitness, strength, sleep, smoking, screening, medication) rather than number of tests: physician-led programmes, academic clinics, blood-panel subscriptions, concierge memberships, scan-led clinics.
- What tests do top longevity clinics typically include?
The tests top longevity clinics include, ranked by evidence: standard and advanced blood work (ApoB, Lp(a), insulin, hs-CRP), coronary calcium and CT angiography, DEXA and VO₂max, guideline cancer screening, whole-body MRI, epigenetic clocks, CGM, genomics, microbiome, multi-cancer blood tests — with what each clinic tier includes and what primary care already covers.
- Are longevity clinics worth the cost for lifespan extension?
A pharmacist's verdict on whether longevity clinics are worth the cost for lifespan extension, tier by tier: what in a membership has mortality evidence (blood pressure, ApoB, smoking, GLP-1s, structured coaching), what has none (whole-body MRI, epigenetic age, peptides), what Cochrane found about health checks, and the price of the same evidence through primary care.
- How to compare different longevity clinics and programs?
Eight criteria for comparing longevity clinics and programmes, ranked by how much they separate a good clinic from an expensive one: physician contact, evidence share of the menu, follow-through, credentials, cascade management, total cost, conflicts of interest, published limits — with a scoring sheet.